Literature DB >> 34717061

The Association Between Three Adipocytokines (Adiponectin, Resistin and Visfatin) And Thyroid Status in Patients With Type 2 Diabetes Mellitus and Autoimmune Thyroiditis.

Š Sotak1, Z Schroner, I Lazúrová, M Felšőci, I Jochmanová, D Petrášová, I Bertková, M Mitníková, B Nováková, H Wagnerová, O Bobelová.   

Abstract

Autoimmune thyroiditis (AIT) and type 2 diabetes mellitus (DM2) are the most common endocrinological diseases worldwide. Relation between these diseases explains several hypotheses. One of them is influence of some adipocytokines. This study evaluated association between three adipocytokines (adiponectin, resistin and visfatin) and thyroid and glycid status in patients with DM2 and AIT compared to the control group (CG). The group consisted of four subgroups: patients with DM2 without thyreopathies, patients with AIT on substitution therapy without diabetes and prediabetes, patients with DM2 and AIT on substitution therapy and healthy subjects as the CG. We investigated parameters of thyroid and glucose metabolism and serum levels of three adipocytokines. The mean level of resistin in the group of patients with diabetes and thyroiditis was significantly higher than in patients with thyroiditis without diabetes and than in the CG. We found a weak negative correlation between visfatin and fasting glucose levels in patients with thyroiditis without diabetes. We detected a weak negative correlation between resistin and glycated haemoglobin and a weak negative correlation between visfatin and thyroid gland volume in patients with diabetes without thyroiditis. In the CG we determined a weak positive correlation between visfatin and free thyroxin. Our results are consistent with several studies, which confirmed association between AIT and adipocytokines.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34717061      PMCID: PMC8815473          DOI: 10.33549/physiolres.934701

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  40 in total

Review 1.  Resistin and adiponectin--of mice and men.

Authors:  Michael Stumvoll; Hans Häring
Journal:  Obes Res       Date:  2002-11

2.  Resistin levels are normal in hypothyroidism and remain unchanged after attainment of euthyroidism: relationship with insulin levels and anthropometric parameters.

Authors:  G E Krassas; N Pontikides; K Loustis; G Koliakos; T Constantinidis; T Kaltsas
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

3.  Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

Authors:  Alexander R Moschen; Arthur Kaser; Barbara Enrich; Birgit Mosheimer; Milan Theurl; Harald Niederegger; Herbert Tilg
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

4.  Visfatin, Leptin, and TNF-α: Interrelated Adipokines in Insulin-Resistant Clinical and Subclinical Hypothyroidism.

Authors:  Savas Guzel; Arzu Seven; Eda Celik Guzel; Banu Buyuk; Aslan Celebi; Birsen Aydemir
Journal:  Endocr Res       Date:  2013-01-16       Impact factor: 1.720

5.  Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function.

Authors:  M Ozkaya; M Sahin; E Cakal; F Yuzbasioglu; K Sezer; M Kilinc; S Simsek Imrek
Journal:  J Endocrinol Invest       Date:  2009-05-15       Impact factor: 4.256

6.  Novel interactions of adiponectin with the endocrine system and inflammatory parameters.

Authors:  José Manuel Fernández-Real; Abel López-Bermejo; Roser Casamitjana; Wifredo Ricart
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

7.  Effect of triiodothyronine on adiponectin expression and leptin release by white adipose tissue of normal rats.

Authors:  A Cabanelas; A Cordeiro; N A dos Santos Almeida; G S Monteiro de Paula; V M Coelho; T M Ortiga-Carvalho; C C Pazos-Moura
Journal:  Horm Metab Res       Date:  2010-01-21       Impact factor: 2.936

8.  Adiponectin is independently associated with glycosylated haemoglobin.

Authors:  José Manuel Fernández-Real; Patricia Botas-Cervero; Abel López-Bermano; Roser Casamitjana; Tohru Funahashi; Elías Delgado; Shinji Kihara; Wifredo Ricart
Journal:  Eur J Endocrinol       Date:  2004-02       Impact factor: 6.664

9.  Serum visfatin and fetuin-a levels and glycemic control in patients with obese type 2 diabetes mellitus.

Authors:  Fethiye Oztop Gunduz; Sembol Turkmen Yildirmak; Mustafa Temizel; Yilmaz Faki; Mustafa Cakmak; Mustafa Durmuscan; Funda Sezgin
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

10.  Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: An experimental and clinical update.

Authors:  Nese Cinar; Alper Gurlek
Journal:  Endocr Connect       Date:  2013-10-24       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.